| 51 |
32730183 | Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). | 2020 Oct 10 |
1 |
| 52 |
32766857 | Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial. | 2020 Aug 11 |
1 |
| 53 |
32847118 | Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP. | 2020 Aug 24 |
1 |
| 54 |
33091357 | A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise. | 2020 Nov |
1 |
| 55 |
33230132 | Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas. | 2020 Nov 23 |
1 |
| 56 |
33269174 | DA-REPOCH Versus R-CHOP for the Treatment of Activated B-Cell Subtype Diffuse Large B-Cell Lymphoma: A Community Center Experience. | 2020 Nov 26 |
1 |
| 57 |
33317571 | New agents and regimens for diffuse large B cell lymphoma. | 2020 Dec 14 |
1 |
| 58 |
33323828 | R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms. | 2020 Dec 8 |
1 |
| 59 |
33384022 | Novel targeted therapies of T cell lymphomas. | 2020 Dec 31 |
1 |
| 60 |
30307363 | Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). | 2019 |
1 |
| 61 |
30606932 | [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]. | 2019 |
1 |
| 62 |
30689468 | Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. | 2019 Aug |
1 |
| 63 |
30868028 | Diffuse Large B-cell Lymphoma Presenting as Bilateral Renal Masses: Successful Treatment with Dose-adjusted REPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy Regimen. | 2019 Jan 2 |
1 |
| 64 |
30992670 | Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis. | 2019 |
1 |
| 65 |
31251343 | A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02). | 2019 Oct 23 |
1 |
| 66 |
31280230 | Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan. | 2019 Jul-Aug |
1 |
| 67 |
31305432 | Upper gastrointestinal bleeding caused by direct invasion of diffuse large B-cell lymphoma into the stomach in a patient with HIV infection: A case report. | 2019 Jul |
1 |
| 68 |
31314918 | Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms. | 2019 Nov |
1 |
| 69 |
31335477 | A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma. | 2019 Aug 5 |
2 |
| 70 |
31452347 | Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report. | 2019 Oct |
1 |
| 71 |
31516154 | Erythema Gyratum Repens Associated With Diffuse B-cell Lymphoma-Report of A Rare Case. | 2019 Jul-Aug |
1 |
| 72 |
31543772 | R-CHOP-Associated Graves' Hyperthyroidism. | 2019 May-Aug |
1 |
| 73 |
31818069 | [Clinicopathological features of primary cardiac CD5-positive and bcl-2 and C-MYC double expression diffuse large B-cell lymphoma]. | 2019 Dec 8 |
1 |
| 74 |
31852157 | A case report on the effect of rituximab on pyothorax-associated lymphoma. | 2019 Dec |
1 |
| 75 |
31868632 | Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. | 2019 Dec 21 |
1 |
| 76 |
29086009 | Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. | 2018 Jan |
1 |
| 77 |
29252084 | Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. | 2018 Aug |
1 |
| 78 |
29380942 | Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. | 2018 Sep |
1 |
| 79 |
29387400 | Primary skeletal muscle lymphoma: A case report. | 2018 Jan |
1 |
| 80 |
29415941 | [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy]. | 2018 |
1 |
| 81 |
29674443 | Recent Advances in the Treatment of Peripheral T-Cell Lymphoma. | 2018 Sep |
2 |
| 82 |
29686956 | Management of Primary Mediastinal B-Cell Lymphoma in Pregnancy. | 2018 Feb 21 |
1 |
| 83 |
29716630 | Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. | 2018 May 2 |
1 |
| 84 |
29721381 | FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. | 2018 |
1 |
| 85 |
29737107 | [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases]. | 2018 Jan |
1 |
| 86 |
29750632 | Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial. | 2018 Jul 10 |
1 |
| 87 |
29761908 | Rituximab maintenance therapy of follicular lymphoma in clinical practice. | 2018 May 15 |
1 |
| 88 |
29963517 | Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent. | 2018 Jun |
1 |
| 89 |
30071836 | Case report: persistently seronegative neuroborreliosis in an immunocompromised patient. | 2018 Aug 2 |
1 |
| 90 |
30101910 | The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma. | 2018 Dec 15 |
1 |
| 91 |
30147970 | Primary Cardiac Lymphoma: Importance of Tissue Diagnosis. | 2018 |
1 |
| 92 |
30172345 | Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study. | 2018 Sep |
1 |
| 93 |
30190020 | Alkylating Agents in the Treatment of Waldenström Macroglobulinemia. | 2018 Oct |
1 |
| 94 |
30238070 | Computerized Approach to Creating a Systematic Ontology of Hematology/Oncology Regimens. | 2018 |
1 |
| 95 |
30313105 | Intravascular large B-cell lymphoma presenting as multiple stroke: A case report. | 2018 Oct |
2 |
| 96 |
30340554 | Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience. | 2018 Oct 19 |
1 |
| 97 |
30472108 | Curing diffuse large B-cell lymphomas in elderly patients. | 2018 Dec |
1 |
| 98 |
30788202 | Primary Vaginal Non-Hodgkin Lymphoma. | 2018 Dec 11 |
1 |
| 99 |
28115372 | Peripheral T-cell lymphoma, not otherwise specified. | 2017 Mar 2 |
1 |
| 100 |
28123744 | Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy. | 2017 Jan |
1 |